By name: "KSB-D05-K0103" description: "AI-Enhanced Safety Monitoring Boards: Understanding of AI applications supporting Data Safety Monitoring Boards including automated interi..." version: "1.0.0" domain: "D05" domain_name: "Clinical Trials PV" type: "Knowledge" proficiency_level: "L4" bloom_level: "analyze" triggers: - "explain ai-enhanced safety monitoring boards" - "what is ai-enhanced safety monitoring boards" - "analyze ai-enhanced safety monitoring boards" epa_mapping: "EPA-02, EPA-04, EPA-08" cpa_mapping: "CPA-01, CPA-07" regulatory_refs: ""
KSB-D05-K0103: AI-Enhanced Safety Monitoring Boards
Overview
Domain: D05 - Clinical Trials PV Type: Knowledge Proficiency Level: L4 (Proficient - Independent practice) Bloom Level: Analyze
Description
Understanding of AI applications supporting Data Safety Monitoring Boards including automated interim analysis, AI-generated safety summaries, predictive enrollment modeling, and real-time safety dashboard development.
Context
- Major Section: AI in Clinical Trial Safety
- Section: AI Trial Monitoring
EPA Mapping
- EPA-02:3004-3005
- EPA-04:3009-3010
- EPA-08:3018-3019
CPA Pathway
- CPA-01, CPA-07
Regulatory References
- General PV competency
Instructions
When this skill is activated, Claude should:
- Demonstrate L4 proficiency in ai-enhanced safety monitoring boards
- Apply analyze level cognitive skills to analyze the topic
- Reference relevant regulatory guidance (general PV standards)
- Connect to related EPAs: EPA-02, EPA-04, EPA-08
Key Competencies
- Understanding of AI applications supporting Data Safety Monitoring Boards including automated interim analysis, AI-generated safety summaries, predictive enrollment modeling, and real-time safety dashboard development.
Assessment Criteria
- Can analyze core concepts independently
- Demonstrates understanding of regulatory context
- Applies knowledge appropriately to PV scenarios
Related Skills
- Other D05 skills in AI Trial Monitoring
- Cross-domain integrations per DAG architecture
Generated from PV KSB Framework v1.0 | 2025-12-31